INTRODUCTION
P soriasis affects approximately 1-3% of the population globally, 45% developing lesions before 20 years of age. Children ≤18 years of age have an overall prevalence of psoriasis ≈0.71%, the pustular type accounting for 0.6-7% of the patients. [1] The childhood onset and adult onset disease have some contrasting epidemiological and clinical features [ Table 1 ]. [2] Out of four distinct patterns of pustular psoriasis (PP), annular type is the rarest and generalized pustular psoriasis/von Zumbusch (GPP) is the severest -sometimes, even life-threatening; exanthematic, and localized PP are its remaining types. [3] Around 200 reports of GPP exist in the literature. [4] It presents in children aged 6-10 years, usually abruptly with widespread erythematous patches, followed by superficial yellow, confluent, sterile "pustules" along with constitutional symptoms pustule over the right earlobe. Sore throat, cough, malaise and "feverishness" were present since a week. There was no past or family history of any dermatoses including psoriasis. She had tachycardia (110/min) and pyrexia (101°F). Nails and mucosae were uninvolved. Erythrocyte sedimentation rate (ESR) was 41 mm and leukocyte count, 12,000 cells/cmm. Suspecting drug rash, oral prednisolone (40 mg) was administered. Innumerable pin-head sized pustules coalescing into lakes of pus [ Figure 1b ] manifested next day; cyclosporine (3 mg/kg/day) was now added, suspecting GPP. Pus/blood cultures were sterile. Presence of subcorneal spongiform pustule filled with neutrophils, and absence of papillary dermal edema/perivascular infiltrate on skin histopathology corroborated GPP and excluded AGEP [ Figure 1c ]. On the 4 th day patient became afebrile, prednisolone was withdrawn, and cyclosporine tapered to 2 mg/kg/day. The latter, being unaffordable, was withdrawn after another week and the patient advised narrow-band ultraviolet B (NB-UVB) therapy as an outpatient. The follow-up after a fortnight revealed residual erythema and fine scaling [ Figure 1d ].
DISCUSSION
The diagnostic criteria for GPP [5] are, firstly; clinical findings as mentioned above, secondly; subcorneal spongiform pustules on histopathology, thirdly; any/ many of the laboratory alterations (leukocytosis with left shift, elevated ESR, C-reactive protein, antistreptolysin O antibodies, IgG or IgA, hypoproteinemia, hypocalcemia) and lastly; recurrence clinico-histopathologically. Its patients may have suffered from psoriasis vulgaris (pso + GPP) or may not have (pso − GPP) [ Table 2 ]. [4] Beylot et al. [6] classified GPP clinically into acute, annular and mixed types; only some of the patients of the acute type being ill with intermittent fever, malaise, and arthralgia, others remaining symptomatically well; all develop successive waves of discrete "pustules" on an inflamed, erythematous skin, likely coalescing soon into lakes of pus before drying off and desquamating profuse, thin scales. Annular, the most common type, has well-developed annular plaques, pustules, and scales. The mixed type combines features of the two. Cyclosporine is one of the first-line systemic therapies, others being acitretin, methotrexate, and glucocorticosteroids; the last resorted rarely for acute stage/life-threateningly severe disease. In recalcitrant cases, etanercept (0.4 mg/kg biweekly) is considered the first line, adalimumab and infliximab being other immunobiological options. UVB phototherapy and dapsone, too, have been used successfully. [5] Recently an autosomal recessively inherited familial form of GPP due to a mutation in the gene encoding interleukin-36R antagonist located on chromosome 2q13-q14.1 has also been described. [7] We are keeping this patient under follow up so as not to miss any spontaneous relapse and thereby the unequivocal confirmation of GPP in this, otherwise de novo case of pso − GPP without any family history and with an exceptionally prompt remission.
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